FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/12/038951 [Registered on: 27/12/2021] Trial Registered Prospectively
Last Modified On: 13/12/2021
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   Understanding the role of the pigment producing cells in the formation of keloids 
Scientific Title of Study   Investigating dermal and epidermal cells in keloid pathogenesis 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Aayush Gupta 
Designation  Associate Professor 
Affiliation  Dr. D.Y. Patil Medical College, Hospital and Research centre 
Address  Derpartment of Dermatology, Dr D.Y. Patil Medical College, Pimpri
Derpartment of Dermatology, Dr D.Y. Patil Medical College, Pimpri
Pune
MAHARASHTRA
411018
India 
Phone  9545711211  
Fax    
Email  aayushggupta@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Aayush Gupta 
Designation  Associate Professor 
Affiliation  Dr. D.Y. Patil Medical College, Hospital and Research centre 
Address  Derpartment of Dermatology, Dr D.Y. Patil Medical College, Pimpri
Derpartment of Dermatology, Dr D.Y. Patil Medical College, Pimpri
Pune
MAHARASHTRA
411018
India 
Phone  9545711211  
Fax    
Email  aayushggupta@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Aayush Gupta 
Designation  Associate Professor 
Affiliation  Dr. D.Y. Patil Medical College, Hospital and Research centre 
Address  Derpartment of Dermatology, Dr D.Y. Patil Medical College, Pimpri
Department of Dermatology, Dr D.Y. Patil Medical College, Pimpri
Pune
MAHARASHTRA
411018
India 
Phone  9545711211  
Fax    
Email  aayushggupta@gmail.com  
 
Source of Monetary or Material Support  
Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pune 
 
Primary Sponsor  
Name  IADVL Indian Association of Dermatology Venereology and Leprosy 
Address  314-315, 3rd Floor KM Trade Tower, H 3, Sector 14, Kaushambi, Ghaziabad, Uttar Pradesh. 201010 
Type of Sponsor  Other [National Dermatology association] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  N/A 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Aayush Gupta  Dr. D.Y. Patil Medical College, Hospital and research centre  OPD number 8, First Floor, Department of Dermatology
Pune
MAHARASHTRA 
9545711211

aayushggupta@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethics Committee, Dr. D.Y. Patil Vidyapeeth, Pune  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L918||Other hypertrophic disorders of the skin,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
Comparator Agent  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  Individuals diagnosed with keloid (scar spread beyond original borders and no spontaneous regression within 1 year)

Having taken no treatment for keloids before (Treatment naïve)

Not on any immunomodulator drugs for other conditions

Male and female
Above 18 years age
.
 
 
ExclusionCriteria 
Details   Mixed or unclear diagnosis
 Pregnant/lactating females
 Patients who refuse to participate in the study
 Patients having other diseases like diabetes, or with communicable diseases
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The proposed study is an exploratory study to understand the relation between melanocytes and fibroblasts in keloids. It is not a clinical trial, and hence no success/failure is involved.
Understanding the effect of modulation of melanin content in melanocytes on the fibroblast biology 
1 year 
 
Secondary Outcome  
Outcome  TimePoints 
Understanding the effect of melanocyte-conditioned media (melanocyte secretome) on fibroblast biology (trans-well co-culture set up).  1 year 
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   03/01/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   1. Guy WM, Pattisapu P, Ongkasuwan J, Brissett AE. Creation of a head and neck Keloid quality of life questionnaire. The Laryngoscope. 2015;125(12):2672-6. 2. Robles DT, Berg D. Abnormal wound healing: keloids. Clin Dermatol 2007;25:26–32. 3. Bayat A, Arscott G, Ollier WE, Ferguson MW, et al. Description of site specific morphology of keloid phenotypes in an Afrocaribbean population. Br J Plast Surg 2004;57:122–33. 4. Tan A, Glass DA. Patient-reported outcomes for keloids: a systematic review. Giornale italiano di dermatologia e venereologia: organo ufficiale, Societa italiana di dermatologia e sifilografia. 2019;154(2):148-65.  
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Keloids - benign fibroproliferative tumours that either arise spontaneously or after injury - are characterized by hyperproliferative fibroblasts with an increased tendency to differentiate into myofibroblasts. This deregulation of fibroblast function causes excessive deposition of collagen in the dermis leading to a visible raised scar which may spread beyond the borders of the initial injury. The prevalence of keloids is significantly higher in individuals with skin of colour; around 16 % of people in darkly pigmented populations like African Americans and Asian Americans are known to be affected with keloids. On the other hand, keloids rarely develop in Caucasians, albinos and individuals with vitiligo (on the depigmented patch), all of whom have a lower pigmentation content.

Since keratinocytes, melanocytes and fibroblasts maintain skin homeostasis by closely interacting with each other via several autocrine and paracrine signalling pathways, we hypothesised that either melanocytes per se and/or the melanin content therein could influence fibroblast biology, leading to the development or spread of keloids.

To test the role of perturbed melanocytes - fibroblasts cross talk in keloid pathogenesis, we propose to carry out the following objectives:

A)    Understanding Fibroblast-Melanocyte cross-talk in keloid pathogenesis:

A.1) Understanding the effect of melanocyte-conditioned media (melanocyte secretome) on fibroblast biology (trans-well co-culture set up)

A.2) Understanding the effect of modulation of melanin content in melanocytes on the fibroblast biology


 
Close